For Recurrent C. Diff, Tapered/Pulsed Antibiotic Didn't Beat Standard Course

(MedPage Today) — ATLANTA — A tapered and pulsed course of vancomycin was not significantly better than a standard course of the drug for treating a first or second recurrence of Clostridioides difficile infection, a randomized, double-blind…

Source link : https://www.medpagetoday.com/meetingcoverage/idweek/118136

Author :

Publish date : 2025-10-24 17:46:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

For Recurrent C. Diff, Tapered/Pulsed Antibiotic Didn’t Beat Standard Course

Both High and Low Temperatures Tied to Death Risk in HF

Novel Nonhormonal Drug Approved for Menopause Hot Flashes

Related Posts

PFAS Exposure and Brain Development; Food Insecurity and Blood Pressure

ACOG President: Changing Tylenol’s Label Will Drive Baseless Fear

Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial

Who Benefits From the MAHA Anti-Science Push?

Parents urged to vaccinate children as flu cases rise

Home Defibrillators Boost Survival, but Fall Short on Cost-Effectiveness

PFAS Exposure and Brain Development; Food Insecurity and Blood Pressure

ACOG President: Changing Tylenol’s Label Will Drive Baseless Fear

Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial

Who Benefits From the MAHA Anti-Science Push?

Parents urged to vaccinate children as flu cases rise

Home Defibrillators Boost Survival, but Fall Short on Cost-Effectiveness

Early Natural Menopause Linked to 27% Higher Risk

Patients With Pancreatic Cancer May Live Longer With Surgery Alone — With a Catch

Categories

Archives